Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-055041
Filing Date
2005-11-02
Accepted
2005-11-02 15:50:02
Documents
2
Period of Report
2005-10-31

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION y14212_nv.html 4  
1 MAIN DOCUMENT DESCRIPTION y14212_nv.xml 4 4456
2 ADDITIONAL EXHIBITS jfi.txt EX-99 1783
  Complete submission text file 0001209191-05-055041.txt   8769
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Reporting) CIK: 0001030617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49839 | Film No.: 051173218

Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Issuer) CIK: 0001093649 (see all company filings)

EIN.: 450478605
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-49839 | Film No.: 051173219
SIC: 2834 Pharmaceutical Preparations